2024 State of Validation Report

Jonathan Kay

Unlock the latest insights and trends in validation practices with the 2024 State of Validation report. Authored by life sciences industry expert and Harvard alumnus Jonathan Kay, the State of Validation comprises a broad quantitative and qualitative primary market research study, conducted directly with validation professionals worldwide.

The report captures a snapshot of the forces impacting the validation industry and tracks trends over time.

From technological and regulatory change to commercial and market influences, organizational change and strategy, professional development, salary insights, and more, the 2024 State of Validation report is a comprehensive analysis of the validation industry.

Download Now to Explore:

Key challenges including compliance burden, audit readiness, and data integrity.
Strategic focuses on process efficiencies, audit success, and harmonizing processes across sites.
Emerging KPIs such as, cost savings, and product quality improvement.
Long-term shifts towards digital validation systems and remote regulatory audits.
The growing adoption of Pharma 4.0 technologies and Computer Software Assurance (CSA) processes.

About Kneat

Kneat Solutions Inc. (TSX: KSI) provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. We lead the industry in customer satisfaction with an unblemished record for retention and implementation, powered by our user-friendly design, expert support, and on-demand training academy.

Download Sponsored Content

To download this sponsored content, complete the form below. Once submitted, you will receive a link via the email you provided to download the sponsored content.

First

Last

Company Name

Company Type

Job Level

Address

City/Town

State/Province

ZIP/Postal Code

Country

Phone

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Information Systems

Pharma 4.0™ Validation

Sponsored Content

Alcohols for Use as an Antimicrobial Agent

1 September 2024

In healthcare and pharmaceutical settings, alcohol refers to two water-soluable chemical compounds, ethyl alcohol and isopropyl alcohol, that can be used as antimicrobial agents. Isopropyl alcohol is widely used as a sanitizing agent in pharmaceutical companies. It is used to avoid the risk of cross-contamination by microorganisms. Alcohols have also been used as hard surface (nonskin)...

Sponsored Content

Real-Time Process Monitoring: Why Have It and How to Get It

1 September 2024

Real-time process monitoring involves integrating physical sensors into production processes to acquire sampling methods. This approach is crucial for both the pharmaceutical and biopharmaceutical industries due to the complexity and sensitivity of synthetic and biological products. Implementing real-time monitoring ensures product quality, improved throughput, safety, and compliance by...

Sponsored Content

The CDMO Handbook: Overcoming Industry Challenges With Digital Validation

1 September 2024

Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) face unique challenges in managing regulatory requirements and getting to market. This eBook, written by CDMO and Audit expert Joe Azzarella, demonstrates why digital validation seems purpose-built for CDMOs.